Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 36

Sort by

Sort Order Select

Journal Articles

Nanobody-based Naturally Selected CD7-Targeted CAR-T Therapy for Acute Myeloid Leukemia

Peihua Lu, Xian Zhang, Junfang Yang, Jingjing Li, Liyuan Qiu, Meiwei Gong, Hui Wang, Jiaqi Chen, Hongxing Liu, Min Xiong, Ying Liu, Lin Wang

Blood blood.2024024861.

https://doi.org/10.1182/blood.2024024861

Published: 2024

Includes: Supplemental data

Journal Articles

Busulfan-Based Intensified Myeloablative Conditioning Regimen Allogeneic Hematopoietic Cell Transplantation for Juvenile Myelomonocytic Leukemia-Single Center Study

Yun Wang, Ruijuan Sun, Yanli Zhao, Zhijie Wei, Min Xiong, Deyan Liu, Peihua Lu, Yue Lu

Blood (2024) 144 (Supplement 1): 7328.

https://doi.org/10.1182/blood-2024-202905

Published: 2024

Journal Articles

Comparable OS and Gffs of ATLG Vs. Ratg for Gvhd Prophylaxis in Pediatric AA Patients Undergoing Transplantation

Li Nannan, Yue Lu, Deyan Liu, Min Xiong, Yanli Zhao, Ruijuan Sun, Zhijie Wei, Xingyu Cao, Jiarui Zhou, Jianping Zhang, Peihua Lu

Blood (2024) 144 (Supplement 1): 3537.

https://doi.org/10.1182/blood-2024-209027

Published: 2024

Journal Articles

Long-Term Efficacy of Allogeneic Hematopoietic Stem Cell Transplantation for 532 Patients with KMT2A-Rearranged Acute Leukemia

Ruijuan Sun, Yue Lu, Jian-Ping Zhang, Jiarui Zhou, Deyan Liu, Yanli Zhao, Zhijie Wei, Min Xiong, Xingyu Cao, Peihua Lu

Blood (2024) 144 (Supplement 1): 3546.

https://doi.org/10.1182/blood-2024-206907

Published: 2024

Journal Articles

Pharmacological Evaluation of a First-in-Class Hemoglobin Elevating Agent (HbEA) AND017 in Townes SCD Mouse Model

Gang Huang, Jie Bai, Mingzhe Pan, Dong Liu, Min Xiong, Shaojiang Deng

Blood (2024) 144 (Supplement 1): 2488.

https://doi.org/10.1182/blood-2024-208058

Published: 2024

Journal Articles

Pharmacological Evaluation of a First-in-Class Hemoglobin Elevating Agent (HbEA) AND017 in a Mouse MDS Model of an Inducible Mutant c-Myc Knock-in

Gang Huang, Jie Bai, Mingzhe Pan, Dong Liu, Min Xiong, Shaojiang Deng

Blood (2024) 144 (Supplement 1): 4140.

https://doi.org/10.1182/blood-2024-207858

Published: 2024

Journal Articles

Pharmacological Evaluation of a First-in-Class Hemoglobin Elevating Agent (HbEA) AND017 in a Hbb d3th β-Thalassemia Mouse Model

Dong Liu, Min Xiong, Shaojiang Deng

Blood (2024) 144 (Supplement 1): 2477.

https://doi.org/10.1182/blood-2024-200015

Published: 2024

Journal Articles

A Long-Term Follow-up Retrospective Study of the Clinical Efficacy of Haploidentical Hematopoietic Stem Cell Transplantation for Early T-Precursor Acute Lymphoblastic Leukemia and T-Lymphoblastic Lymphoma

Xingyu Cao, Yue Lu, Jian-Ping Zhang, Deyan Liu, Zhijie Wei, Yanli Zhao, Jiarui Zhou, Min Xiong, Ruijuan Sun, Jing Long, Peihua Lu

Blood (2024) 144 (Supplement 1): 4934.

https://doi.org/10.1182/blood-2024-204579

Published: 2024

Journal Articles

Efficacy and Safety Analysis of Prophylactic Brentuximab Vedotin Administration after Pediatric Acute Leukemia Haploidentical Hematopoietic Stem Cell Transplantation

Huili Zhu, Xingyu Cao, Yue Lu, Yanli Zhao, Jianping Zhang, Deyan Liu, Min Xiong, Ruijuan Sun, Hongxing Liu, Zhijie Wei

Blood (2023) 142 (Supplement 1): 7009.

https://doi.org/10.1182/blood-2023-184500

Published: 2023

Journal Articles

CD7 CAR-T Therapy Followed By a Second Transplant for T-Cell Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma Patients Who Relapsed after a Prior Transplant

Xingyu Cao, Jianping Zhang, Yue Lu, Yanli Zhao, Deyan Liu, Min Xiong, Zhijie Wei, Jiarui Zhou, Xian Zhang, Junfang Yang, Hongxing Liu, Peihua Lu

Blood (2023) 142 (Supplement 1): 2155.

https://doi.org/10.1182/blood-2023-186030

Published: 2023

Journal Articles

Naturally Selected CD7-Targeted Chimeric Antigen Receptor (CAR)-T Cell Therapy for Refractory/Relapsed Acute Myeloid Leukemia: Phase I Clinical Trial

Xian Zhang, Junfang Yang, Jingjing Li, Liyuan Qiu, Hongxing Liu, Sr., Min Xiong, Jianqiang Li, Peihua Lu

Blood (2023) 142 (Supplement 1): 218.

https://doi.org/10.1182/blood-2023-179086

Published: 2023

Journal Articles

A Parallel Comparison of the Safety and Efficacy of Allogeneic Hematopoietic Stem Cell Transplantation for Refractory and Relapsed T-ALL/Lbl Patients Who Achieved Complete Remission with CD7 CAR-T Versus Patients Who Achieved First Complete Remission with Chemotherapy before Transplantation

Xingyu Cao, Jianping Zhang, Yue Lu, Yanli Zhao, Deyan Liu, Min Xiong, Ruijuan Sun, Zhijie Wei, Jiarui Zhou, Xian Zhang, Junfang Yang, Hongxing Liu, Sr., Peihua Lu

Blood (2023) 142 (Supplement 1): 3611.

https://doi.org/10.1182/blood-2023-185696

Published: 2023

Journal Articles

Short-Term Efficacy and Safety of Haplo Hematopoietic Stem Cell Transplantation for Refractory and/or Relapsed Leukemia

Wei Zhao, Min Xiong, Yanli Zhao, Man Chen, Hui Wang, Peihua Lu

Blood (2022) 140 (Supplement 1): 12961–12962.

https://doi.org/10.1182/blood-2022-166724

Published: 2022

Journal Articles

Analysis Benefits of a Second Allo-HSCT after CAR-T Cell Therapy in 97 Patients with Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia Who Relapsed after a First Transplant

Xing-yu Cao, Jian-Ping Zhang, Yan-Li Zhao, Min Xiong, Jiarui Zhou, Yue Lu, Ruijuan Sun, Zhijie Wei, Deyan Liu, Xian Zhang, Junfang Yang, Peihua Lu

Blood (2022) 140 (Supplement 1): 4802–4803.

https://doi.org/10.1182/blood-2022-166993

Published: 2022

Journal Articles

Clinical Analysis of Air-Leak Syndrome Following Allogeneic Hematopoietic Stem Cell Transplantation in Pediatric Patients

Wei Zhao, Man Chen, Yanli Zhao, Hui Wang, Peihua Lu, Min Xiong

Blood (2021) 138 (Supplement 1): 4870.

https://doi.org/10.1182/blood-2021-152138

Published: 2021

Journal Articles

Significant Long-Term Benefits of CAR T-Cell Therapy Followed By a Second Allo-HSCT for Relapsed/Refractory (R/R) B-Cell Acute Lymphoblastic Leukemia (B-ALL) Patients Who Relapsed after an Initial Transplant

Jianping Zhang, Junfang Yang, Xian Zhang, MD, Jingjing Li, Xingyu Cao, Yanli Zhao, Zhijie Wei, Deyan Liu, Min Xiong, Yue Lu, Jiarui Zhou, Ruijuan Sun, Peihua Lu, MD

Blood (2020) 136 (Supplement 1): 40–41.

https://doi.org/10.1182/blood-2020-136014

Published: 2020

Journal Articles

Alternative Donor and Disease-Specific Conditioning Regimen Hematopoietic Stem Cell Transplantation for Inherited Bone Marrow Failure Syndromes

Fang Xu, Min Xiong, Ruijuan Sun, Yanli Zhao, Jianping Zhang, Xingyu Cao, Deyan Liu, Zhijie Wei, Jiarui Zhou, Yue Lu, Peihua Lu, Daopei Lu

Blood (2019) 134 (Supplement_1): 2047.

https://doi.org/10.1182/blood-2019-125695

Published: 2019

Journal Articles

CD19-CAR-T Therapy Followed By Allogeneic Hematopoietic Stem Cell Transplantation in Refractory/Relapsed and High Risk B-Cell Acute Lymphoblastic Leukemia

Yanli Zhao, Jianping Zhang, Deyan Liu, Min Xiong, Zhijie Wei, Ruijuan Sun, Jiarui Zhou, Yue Lu, Xingyu Cao, Junfang Yang, MD, Xian Zhang, PhD, Hui Wang, PhD, Hongxing Liu, MD, Peihua Lu, Daopei Lu

Blood (2018) 132 (Supplement 1): 2660.

https://doi.org/10.1182/blood-2018-99-118852

Published: 2018

Journal Articles

Allogeneic Transplantation for Minimal Residual Disease Negative Acute Lymphoblastic Leukemia According to 2016 Who Classification: A Single Center Retrospective Analysis

Xingyu Cao, Deyan Liu, Jianping Zhang, Zhijie Wei, Min Xiong, Yue Lu, Yanli Zhao, Jiarui Zhou, Ruijuan Sun, Hongxing Liu, MD

Blood (2018) 132 (Supplement 1): 5786.

https://doi.org/10.1182/blood-2018-99-116119

Published: 2018

Journal Articles

Efficacy and Safety of CD19 Chimeric Antigen Receptor (CAR) T Cell Therapy for B-Cell Acute Lymphocytic Leukemia (B-cell ALL) in a Large Cohort Including Patients with Extramedullary Disease(EMD), High Leukemia Burden, BCR-ABL (+) Mutation,TP53 Mutation, and Post-Transplant Relapse

Xian Zhang, PhD, Xin-an Lu, Junfang Yang, MD, Fanyong LV, Min Xiong, Jianping Zhang, Xiaosu Zhou, Ting He, Peihua Lu

Blood (2018) 132 (Supplement 1): 280.

https://doi.org/10.1182/blood-2018-99-115642

Published: 2018

NARROW

Nanobody-based Naturally Selected CD7-Targeted CAR-T Therapy for Acute Myeloid Leukemia

Busulfan-Based Intensified Myeloablative Conditioning Regimen Allogeneic Hematopoietic Cell Transplantation for Juvenile Myelomonocytic Leukemia-Single Center Study

Comparable OS and Gffs of ATLG Vs. Ratg for Gvhd Prophylaxis in Pediatric AA Patients Undergoing Transplantation

Long-Term Efficacy of Allogeneic Hematopoietic Stem Cell Transplantation for 532 Patients with KMT2A-Rearranged Acute Leukemia

Pharmacological Evaluation of a First-in-Class Hemoglobin Elevating Agent (HbEA) AND017 in Townes SCD Mouse Model

Pharmacological Evaluation of a First-in-Class Hemoglobin Elevating Agent (HbEA) AND017 in a Mouse MDS Model of an Inducible Mutant c-Myc Knock-in

Pharmacological Evaluation of a First-in-Class Hemoglobin Elevating Agent (HbEA) AND017 in a Hbb d3th β-Thalassemia Mouse Model

A Long-Term Follow-up Retrospective Study of the Clinical Efficacy of Haploidentical Hematopoietic Stem Cell Transplantation for Early T-Precursor Acute Lymphoblastic Leukemia and T-Lymphoblastic Lymphoma

Efficacy and Safety Analysis of Prophylactic Brentuximab Vedotin Administration after Pediatric Acute Leukemia Haploidentical Hematopoietic Stem Cell Transplantation

CD7 CAR-T Therapy Followed By a Second Transplant for T-Cell Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma Patients Who Relapsed after a Prior Transplant

Naturally Selected CD7-Targeted Chimeric Antigen Receptor (CAR)-T Cell Therapy for Refractory/Relapsed Acute Myeloid Leukemia: Phase I Clinical Trial

A Parallel Comparison of the Safety and Efficacy of Allogeneic Hematopoietic Stem Cell Transplantation for Refractory and Relapsed T-ALL/Lbl Patients Who Achieved Complete Remission with CD7 CAR-T Versus Patients Who Achieved First Complete Remission with Chemotherapy before Transplantation

Short-Term Efficacy and Safety of Haplo Hematopoietic Stem Cell Transplantation for Refractory and/or Relapsed Leukemia

Analysis Benefits of a Second Allo-HSCT after CAR-T Cell Therapy in 97 Patients with Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia Who Relapsed after a First Transplant

Clinical Analysis of Air-Leak Syndrome Following Allogeneic Hematopoietic Stem Cell Transplantation in Pediatric Patients

Significant Long-Term Benefits of CAR T-Cell Therapy Followed By a Second Allo-HSCT for Relapsed/Refractory (R/R) B-Cell Acute Lymphoblastic Leukemia (B-ALL) Patients Who Relapsed after an Initial Transplant

Alternative Donor and Disease-Specific Conditioning Regimen Hematopoietic Stem Cell Transplantation for Inherited Bone Marrow Failure Syndromes

CD19-CAR-T Therapy Followed By Allogeneic Hematopoietic Stem Cell Transplantation in Refractory/Relapsed and High Risk B-Cell Acute Lymphoblastic Leukemia

Allogeneic Transplantation for Minimal Residual Disease Negative Acute Lymphoblastic Leukemia According to 2016 Who Classification: A Single Center Retrospective Analysis

Efficacy and Safety of CD19 Chimeric Antigen Receptor (CAR) T Cell Therapy for B-Cell Acute Lymphocytic Leukemia (B-cell ALL) in a Large Cohort Including Patients with Extramedullary Disease(EMD), High Leukemia Burden, BCR-ABL (+) Mutation,TP53 Mutation, and Post-Transplant Relapse

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only